Effects of Transmitters and Amyloid-Beta Peptide on Calcium Signals in Rat Cortical Astrocytes: Fura-2AM Measurements and Stochastic Model Simulations

Background To better understand the complex molecular level interactions seen in the pathogenesis of Alzheimer's disease, the results of the wet-lab and clinical studies can be complemented by mathematical models. Astrocytes are known to become reactive in Alzheimer's disease and their ionic equilibrium can be disturbed by interaction of the released and accumulated transmitters, such as serotonin, and peptides, including amyloid- peptides (A). We have here studied the effects of small amounts of A25–35 fragments on the transmitter-induced calcium signals in astrocytes by Fura-2AM fluorescence measurements and running simulations of the detected calcium signals. Methodology/Principal Findings Intracellular calcium signals were measured in cultured rat cortical astrocytes following additions of serotonin and glutamate, or either of these transmitters together with A25–35. A25–35 increased the number of astrocytes responding to glutamate and exceedingly increased the magnitude of the serotonin-induced calcium signals. In addition to A25–35-induced effects, the contribution of intracellular calcium stores to calcium signaling was tested. When using higher stimulus frequency, the subsequent calcium peaks after the initial peak were of lower amplitude. This may indicate inadequate filling of the intracellular calcium stores between the stimuli. In order to reproduce the experimental findings, a stochastic computational model was introduced. The model takes into account the major mechanisms known to be involved in calcium signaling in astrocytes. Model simulations confirm the principal experimental findings and show the variability typical for experimental measurements. Conclusions/Significance Nanomolar A25–35 alone does not cause persistent change in the basal level of calcium in astrocytes. However, even small amounts of A25–35, together with transmitters, can have substantial synergistic effects on intracellular calcium signals. Computational modeling further helps in understanding the mechanisms associated with intracellular calcium oscillations. Modeling the mechanisms is important, as astrocytes have an essential role in regulating the neuronal microenvironment of the central nervous system.

[1]  Olli Yli-Harja,et al.  Stochastic Differential Equation Model for Cerebellar Granule Cell Excitability , 2008, PLoS Comput. Biol..

[2]  M. Duchen,et al.  Calcium signals induced by amyloid beta peptide and their consequences in neurons and astrocytes in culture. , 2004, Biochimica et biophysica acta.

[3]  R. Liu,et al.  RETRACTED: S14G-Humanin ameliorates Aβ25-35-induced behavioral deficits by reducing neuroinflammatory responses and apoptosis in mice , 2008, Neuropeptides.

[4]  H. Kimelberg,et al.  Dissociation of neonatal rat brain by dispase for preparation of primary astrocyte cultures , 1984, Neurochemical Research.

[5]  H. Fukuyama,et al.  Peripheral Aβ subspecies as risk biomarkers of Alzheimer's disease , 2008, Proceedings of the National Academy of Sciences.

[6]  Kim N. Green,et al.  Linking Calcium to Aβ and Alzheimer's Disease , 2008, Neuron.

[7]  Keijo Ruohonen,et al.  Developing Itô stochastic differential equation models for neuronal signal transduction pathways , 2006, Comput. Biol. Chem..

[8]  O. Yli-Harja,et al.  Modeling G-Protein Induced Protein Kinase C Activation Cascade: Deterministic and Stochastic Simulations , 2007, 2007 IEEE International Workshop on Genomic Signal Processing and Statistics.

[9]  Frank M LaFerla,et al.  Calcium dysregulation in Alzheimer's disease: recent advances gained from genetically modified animals. , 2005, Cell calcium.

[10]  Matjaz Perc,et al.  Establishing the stochastic nature of intracellular calcium oscillations from experimental data. , 2008, Biophysical chemistry.

[11]  M. Beal,et al.  An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[12]  D. Gillespie Exact Stochastic Simulation of Coupled Chemical Reactions , 1977 .

[13]  M. Mattson Pathways towards and away from Alzheimer's disease , 2004, Nature.

[14]  B. Pakkenberg,et al.  A neural cell adhesion molecule–derived peptide reduces neuropathological signs and cognitive impairment induced by Aβ25-35 , 2007, Neuroscience.

[15]  Todd A Fiacco,et al.  What Is the Role of Astrocyte Calcium in Neurophysiology? , 2008, Neuron.

[16]  Dan ie l T. Gil lespie A rigorous derivation of the chemical master equation , 1992 .

[17]  D. Gillespie A General Method for Numerically Simulating the Stochastic Time Evolution of Coupled Chemical Reactions , 1976 .

[18]  C. Herron,et al.  A beta 25-35-induced depression of long-term potentiation in area CA1 in vivo and in vitro is attenuated by verapamil. , 2003, Journal of neurophysiology.

[19]  Helmut Kettenmann,et al.  Calcium signalling in glial cells , 1996, Trends in Neurosciences.

[20]  Maxim Lavrentovich,et al.  A mathematical model of spontaneous calcium(II) oscillations in astrocytes. , 2008, Journal of theoretical biology.

[21]  Angelo Di Garbo,et al.  Dynamics of a minimal neural model consisting of an astrocyte, a neuron, and an interneuron , 2009, Journal of biological physics.

[22]  P. Haydon,et al.  Physiological astrocytic calcium levels stimulate glutamate release to modulate adjacent neurons. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Lin Lin,et al.  Panaxydol and panaxynol protect cultured cortical neurons against Aβ25–35-induced toxicity , 2008, Neuropharmacology.

[24]  H. Kimelberg,et al.  Serotonin induces inward potassium and calcium currents in rat cortical astrocytes , 1997, Brain Research.

[25]  Angelo Di Garbo,et al.  Calcium signalling in astrocytes and modulation of neural activity , 2007, Biosyst..

[26]  M. Findeis The role of amyloid β peptide 42 in Alzheimer's disease , 2007 .

[27]  A. Charles,et al.  Intercellular calcium waves in glia , 1998, Glia.

[28]  M. Mattson,et al.  Calcium and neurodegeneration , 2007, Aging cell.

[29]  S. Goderie,et al.  Transmitter‐Induced Calcium Responses Differ in Astrocytes Acutely Isolated from Rat Brain and in Culture , 1997, Journal of neurochemistry.

[30]  J. Davies,et al.  Molecular Biology of the Cell , 1983, Bristol Medico-Chirurgical Journal.

[31]  H. Mkrtchian,et al.  Neuroprotection by hypothalamic peptide proline-rich peptide-1 in Aβ25–35 model of Alzheimer's disease , 2008, Alzheimer's & Dementia.

[32]  Giuseppe Sorrentino,et al.  Solution structure of amyloid beta-peptide (25-35) in different media. , 2004, Journal of medicinal chemistry.

[33]  F. Nicoletti,et al.  Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders? , 1996, Trends in Neurosciences.

[34]  J. Qi,et al.  Amyloid β‐protein fragments 25–35 and 31–35 potentiate long‐term depression in hippocampal CA1 region of rats in vivo , 2009, Synapse.

[35]  M. Falcke Reading the patterns in living cells —the physics of ca2+ signaling , 2004 .

[36]  D. B. Wielt,et al.  β-Amyloid peptide-induced morphological changes coincide with increased K+ and Cl− channel activity in rat cortical astrocytes , 1997, Brain Research.

[37]  Matjaz Perc,et al.  Importance of cell variability for calcium signaling in rat airway myocytes. , 2010, Biophysical chemistry.

[38]  P. Agostinho,et al.  Susceptibility of hippocampal neurons to Aβ peptide toxicity is associated with perturbation of Ca2+ homeostasis , 2007, Brain Research.

[39]  Darren J. Wilkinson Stochastic Modelling for Systems Biology , 2006 .

[40]  G. Perea,et al.  Synaptic regulation of the astrocyte calcium signal , 2004, Journal of Neural Transmission.

[41]  B. Sacchetti,et al.  Astrocyte modulation of in vitro β‐amyloid neurotoxicity , 2004, Glia.

[42]  H. Kettenmann,et al.  Gamma-aminobutyric acid and glutamate receptors , 1995 .

[43]  Michael M. Halassa,et al.  The tripartite synapse: roles for gliotransmission in health and disease. , 2007, Trends in molecular medicine.

[44]  U. Bhalla,et al.  Emergent properties of networks of biological signaling pathways. , 1999, Science.

[45]  J. Kuźnicki,et al.  Calcium dysregulation in Alzheimer's disease , 2008, Neurochemistry International.

[46]  Grace E. Stutzmann The Pathogenesis of Alzheimers Disease—Is It a Lifelong “Calciumopathy”? , 2007, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[47]  Matjaz Perc,et al.  Prevalence of stochasticity in experimentally observed responses of pancreatic acinar cells to acetylcholine. , 2009, Chaos.

[48]  M. Mattson,et al.  Capacitative Calcium Entry Deficits and Elevated Luminal Calcium Content in Mutant Presenilin-1 Knockin Mice , 2000, The Journal of cell biology.

[49]  S. Murphy,et al.  Astrocytes: Pharmacology and Function edited by J. Murphy, Academic Press, 1993. £75.00 (xx + 457 pages) ISBN 0 12511370 6 , 1994, Trends in Neurosciences.

[50]  H. Baba,et al.  Serum amyloid β protein in young and elderly depression: a pilot study , 2009, Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society.

[51]  Zaven S. Khachaturian,et al.  Diagnosis of Alzheimer’s disease: Two decades of progress* , 2005, Alzheimer's & Dementia.

[52]  Alfonso Araque,et al.  Glial calcium signaling and neuron-glia communication. , 2005, Cell calcium.

[53]  S. Goderie,et al.  Functional consequences of astrocytic swelling. , 1992, Progress in brain research.

[54]  C. Giaume,et al.  Astrocyte calcium waves: What they are and what they do , 2006, Glia.

[55]  Christian Steinhäuser,et al.  Astrocyte dysfunction in neurological disorders: a molecular perspective , 2006, Nature Reviews Neuroscience.

[56]  L. Venance,et al.  Control and Plasticity of Intercellular Calcium Waves in Astrocytes: A Modeling Approach , 2002, The Journal of Neuroscience.

[57]  F. Nicoletti,et al.  Group-II metabotropic glutamate receptor ligands as adjunctive drugs in the treatment of depression: a new strategy to shorten the latency of antidepressant medication? , 2007, Molecular Psychiatry.

[58]  D. Gillespie The chemical Langevin equation , 2000 .

[59]  H. Kimelberg,et al.  CHAPTER 9 – Regulation of the Brain Microenvironment: Transmitters and Ions , 1993 .

[60]  A. Volterra,et al.  The active role of astrocytes in synaptic transmission , 1999, Cellular and Molecular Life Sciences CMLS.